Company number SC371591
Status Active
Incorporation Date 21 January 2010
Company Type Private Limited Company
Address 7-11 MELVILLE STREET, EDINBURGH, EH3 7PE
Home Country United Kingdom
Nature of Business 82990 - Other business support service activities n.e.c.
Phone, email, etc
Since the company registration twenty-three events have happened. The last three records are Confirmation statement made on 21 January 2017 with updates; Total exemption small company accounts made up to 31 March 2016; Registration of charge SC3715910001, created on 23 June 2016. The most likely internet sites of LINDEN ONCOLOGY LIMITED are www.lindenoncology.co.uk, and www.linden-oncology.co.uk. The predicted number of employees is 1 to 10. The company’s age is fifteen years and eleven months. Linden Oncology Limited is a Private Limited Company.
The company registration number is SC371591. Linden Oncology Limited has been working since 21 January 2010.
The present status of the company is Active. The registered address of Linden Oncology Limited is 7 11 Melville Street Edinburgh Eh3 7pe. . SAUNDERS, Andrew, Dr is a Director of the company. Director MABBOTT, Stephen George has been resigned. The company operates in "Other business support service activities n.e.c.".
Current Directors
Resigned Directors
Persons With Significant Control
Dr Andrew Saunders
Notified on: 6 April 2016
60 years old
Nature of control: Ownership of shares – 75% or more
LINDEN ONCOLOGY LIMITED Events
23 Jan 2017
Confirmation statement made on 21 January 2017 with updates
01 Sep 2016
Total exemption small company accounts made up to 31 March 2016
24 Jun 2016
Registration of charge SC3715910001, created on 23 June 2016
25 Jan 2016
Annual return made up to 21 January 2016 with full list of shareholders
Statement of capital on 2016-01-25
19 Aug 2015
Total exemption small company accounts made up to 31 March 2015
...
... and 13 more events
01 Apr 2010
Appointment of Dr Andrew Saunders as a director
26 Jan 2010
Termination of appointment of Stephen Mabbott as a director
26 Jan 2010
Current accounting period extended from 31 January 2011 to 31 March 2011
26 Jan 2010
Statement of capital following an allotment of shares on 21 January 2010
21 Jan 2010
Incorporation